The end of the risk-treatment paradox?: A rising tide lifts all boats

Journal of the American College of Cardiology

Volumn 58, Issue 17, 2011, Pages 1766-1767

  McAlister, Finlay A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

guideline adherence; myocardial infarction; paradox; risk; trends

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EFFECTIVENESS; COMORBIDITY; CORONARY ARTERY DISEASE; DEFIBRILLATION; HEALTH CARE QUALITY; HEART CATHETERIZATION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; NOTE; OFF LABEL DRUG USE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; SYSTOLIC DYSFUNCTION; TREATMENT INDICATION; UNSTABLE ANGINA PECTORIS;

EID: 80054728019     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.07.028     Document Type: Editorial

References (12)

1. A.A. Motivala, C.P. Cannon, and V.S. Srinivas Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care? J Am Coll Cardiol 58 2011 1760 1765
2. P.N. Peterson, J.S. Rumsfeld, and L. Liang Treatment and risk in heart failure Gaps in evidence or quality? Circ Cardiovasc Qual Outcomes 3 2010 309 315
3. D.T. Ko, J.S. Ross, Y. Wang, and H.M. Krumholz Determinants of cardiac catheterization use in older Medicare patients with acute myocardial infarction Circ Cardiovasc Qual Outcomes 3 2010 54 62
4. T.J. Bungard, W.A. Ghali, and F.A. McAlister Physicians' perceptions of the benefits and risks of warfarin for patients with non-valvular atrial fibrillation CMAJ 165 2001 301 302 (Pubitemid 32881231)
5. A.J. Bagnall, A.T. Yan, and R.T. Yan Optimal medical therapy for non-ST segment elevation acute coronary syndromes Exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after discharge Circ Cardiovasc Qual Outcomes 3 2010 530 537
6. A.T. Yan, R.T. Yan, and T. Huynh Understanding physicians' risk stratification of acute coronary syndromes Insights from the Canadian ACS 2 Registry Arch Intern Med 169 2009 372 378
7. D.C. Radley, S.N. Finkelstein, and R.S. Stafford Off-label prescribing among office-based physicians Arch Intern Med 166 2006 1021 1026
8. S.M. Al-Khatib, A. Hellkamp, and J. Curtis Non-evidence-based ICD implantations in the United States JAMA 305 2011 43 49
9. C. Lenfant Clinical research to clinical practicelost in translation? N Engl J Med 349 2003 868 874
10. D.T. Ko, M. Chiu, and H. Guo Safety and effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications J Am Coll Cardiol 53 2009 1773 1782
11. J.P. Piccini, A.F. Hernandez, and D. Dai Use of cardiac resynchronization therapy in patients hospitalized with heart failure Circulation 118 2008 926 933
12. S.R. Majumdar, F.A. McAlister, and C.D. Furberg From publication to practice in chronic cardiovascular diseasethe long and winding road J Am Coll Cardiol 43 2004 1738 1742 (Pubitemid 38622507)